468 related articles for article (PubMed ID: 30343724)
1. APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
Freedman BI; Limou S; Ma L; Kopp JB
Am J Kidney Dis; 2018 Nov; 72(5 Suppl 1):S8-S16. PubMed ID: 30343724
[TBL] [Abstract][Full Text] [Related]
2. APOL1 Nephropathy: A Population Genetics and Evolutionary Medicine Detective Story.
Kruzel-Davila E; Wasser WG; Skorecki K
Semin Nephrol; 2017 Nov; 37(6):490-507. PubMed ID: 29110756
[TBL] [Abstract][Full Text] [Related]
3. APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.
Kopp JB; Heymann J; Winkler CA
Semin Nephrol; 2017 Nov; 37(6):514-519. PubMed ID: 29110758
[TBL] [Abstract][Full Text] [Related]
4. APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.
Gutiérrez OM; Irvin MR; Zakai NA; Naik RP; Chaudhary NS; Estrella MM; Limou S; Judd SE; Cushman M; Kopp JB; Winkler CA
Am J Kidney Dis; 2020 Jan; 75(1):54-60. PubMed ID: 31563468
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Injury in APOL1-associated Kidney Disease.
Ma L; Divers J; Freedman BI
Transplantation; 2019 Mar; 103(3):487-492. PubMed ID: 30371607
[TBL] [Abstract][Full Text] [Related]
6. APOL1 nephropathy: from gene to mechanisms of kidney injury.
Kruzel-Davila E; Wasser WG; Aviram S; Skorecki K
Nephrol Dial Transplant; 2016 Mar; 31(3):349-58. PubMed ID: 25561578
[TBL] [Abstract][Full Text] [Related]
7. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.
Abdu A; Duarte R; Dickens C; Dix-Peek T; Bala SM; Ademola B; Naicker S
PLoS One; 2022; 17(10):e0275949. PubMed ID: 36227935
[TBL] [Abstract][Full Text] [Related]
8. The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.
Daneshpajouhnejad P; Kopp JB; Winkler CA; Rosenberg AZ
Nat Rev Nephrol; 2022 May; 18(5):307-320. PubMed ID: 35217848
[TBL] [Abstract][Full Text] [Related]
9. A focus on the association of Apol1 with kidney disease in children.
Ekulu PM; Nkoy AB; Adebayo OC; Kazadi OK; Aloni MN; Arcolino FO; Ngiyulu RM; Gini JE; Lepira FB; Van den Heuvel LP; Levtchenko EN
Pediatr Nephrol; 2021 Apr; 36(4):777-788. PubMed ID: 32253519
[TBL] [Abstract][Full Text] [Related]
10. Treatment potential in APOL1-associated nephropathy.
Friedman DJ; Ma L; Freedman BI
Curr Opin Nephrol Hypertens; 2022 Sep; 31(5):442-448. PubMed ID: 35894278
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
Langefeld CD; Comeau ME; Ng MCY; Guan M; Dimitrov L; Mudgal P; Spainhour MH; Julian BA; Edberg JC; Croker JA; Divers J; Hicks PJ; Bowden DW; Chan GC; Ma L; Palmer ND; Kimberly RP; Freedman BI
Kidney Int; 2018 Sep; 94(3):599-607. PubMed ID: 29885931
[TBL] [Abstract][Full Text] [Related]
12. The Impact of APOL1 on Chronic Kidney Disease and Hypertension.
Robinson TW; Freedman BI
Adv Chronic Kidney Dis; 2019 Mar; 26(2):131-136. PubMed ID: 31023447
[TBL] [Abstract][Full Text] [Related]
13. The Cell Biology of APOL1.
O'Toole JF; Bruggeman LA; Madhavan S; Sedor JR
Semin Nephrol; 2017 Nov; 37(6):538-545. PubMed ID: 29110761
[TBL] [Abstract][Full Text] [Related]
14. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
[TBL] [Abstract][Full Text] [Related]
15. Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.
Freedman BI; Skorecki K
Clin J Am Soc Nephrol; 2014 Nov; 9(11):2006-13. PubMed ID: 24903390
[TBL] [Abstract][Full Text] [Related]
16. Host factors predisposing to kidney disease in people with HIV.
Hung RKY; Winkler CA; Post FA
Curr Opin HIV AIDS; 2023 Mar; 18(2):87-92. PubMed ID: 36722197
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
Larsen CP; Beggs ML; Saeed M; Ambruzs JM; Cossey LN; Messias NC; Walker PD; Freedman BI
Mod Pathol; 2015 Jan; 28(1):95-102. PubMed ID: 25081748
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein L1 Gene Effects on Kidney Transplantation.
Freedman BI; Locke JE; Reeves-Daniel AM; Julian BA
Semin Nephrol; 2017 Nov; 37(6):530-537. PubMed ID: 29110760
[TBL] [Abstract][Full Text] [Related]
19. APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
Bruggeman LA; Wu Z; Luo L; Madhavan S; Drawz PE; Thomas DB; Barisoni L; O'Toole JF; Sedor JR
PLoS One; 2019; 14(10):e0224408. PubMed ID: 31661509
[TBL] [Abstract][Full Text] [Related]
20. One Actor, Many Roles: Histopathologies Associated With APOL1 Genetic Variants.
Kopp JB; Rosenberg AZ
Adv Anat Pathol; 2019 May; 26(3):215-219. PubMed ID: 30624253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
